AstraZeneca PLC AZN
Set alert
At close · Oct 30
After hours · Oct 30, 6:29 PM ET
- YTD
- +1.52%
- 1 year
- +13.34%
- Open
- 183.59
- Prev close
- 174.40
- Mkt cap
- 289.48B
- Vol
- 5.47M
- Avg vol
- 3.41M
- EPS
- 6.69
- P/E
- 27.90
- Div yield
- 1.84%
More statistics
- Low
- 183.10
- High
- 188.39
- Forward P/E
- 16.41
- Beta
- 0.21
- Short ratio
- 1.14
- Inst. own
- 76.35%
- Dividend
- 3.20
- Ex-div date
- Aug 6, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 164.04
- 200-d avg
- 180.19
- 1y target
- 206.66
MAX chart
Events in this range
- Apr 7, 1999Dividend: 0.4956
- Sep 6, 2000Dividend: 0.2555
- Feb 7, 2007Dividend: 1.23
- Feb 7, 2008Dividend: 1.35
- Aug 6, 2008Dividend: 0.55
- Feb 4, 2009Dividend: 1.5
- Aug 5, 2009Dividend: 0.59
- Feb 3, 2010Dividend: 1.71
- Aug 4, 2010Dividend: 0.7
- Feb 2, 2011Dividend: 1.85
- Aug 4, 2011Dividend: 0.85
- Apr 2, 2014Dividend: 0
- Jun 5, 2014Dividend: 0
- Nov 6, 2025Earnings: 2.38; estimate 2.28; surprise 4.39%
- Feb 2, 2026Split: 1 for 2
- Aug 7, 2026Dividend: 1.06
- Oct 30, 2026Earnings: 2.79; estimate 2.6; surprise 7.31%
Signals (153)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Feb 1, 2026 | 9 months ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 1, 2024 | 1 year ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 1, 2022 | 4 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 1, 2022 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| MACD: Buy Signal | Jun 1, 2021 | 5 years ago |
| SMA: Bullish | Apr 1, 2021 | 5 years ago |
| SMA: Bearish | Dec 1, 2020 | 5 years ago |
| MACD: Sell Signal | Dec 1, 2020 | 5 years ago |
| SMA: Bullish | Nov 1, 2020 | 6 years ago |
| SMA: Bearish | Oct 1, 2020 | 6 years ago |
| SMA: Bullish | Apr 1, 2020 | 6 years ago |
| SMA: Bearish | Feb 1, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2019 | 7 years ago |
| MACD: Buy Signal | Jun 1, 2019 | 7 years ago |
| MACD: Sell Signal | May 1, 2019 | 7 years ago |
| SMA: Bearish | Apr 1, 2019 | 7 years ago |
| SMA: Bullish | Feb 1, 2019 | 7 years ago |
| SMA: Bearish | Jan 1, 2019 | 7 years ago |
| SMA: Bullish | Mar 1, 2018 | 8 years ago |
| SMA: Bearish | Feb 1, 2018 | 8 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bearish | Aug 1, 2017 | 9 years ago |
| SMA: Bearish | Jul 1, 2017 | 9 years ago |
| SMA: Bullish | May 1, 2017 | 9 years ago |
| MACD: Buy Signal | May 1, 2017 | 9 years ago |
| SMA: Bullish | Mar 1, 2017 | 9 years ago |
| SMA: Bearish | Oct 1, 2016 | 10 years ago |
| SMA: Bearish | Aug 1, 2016 | 10 years ago |
| SMA: Bullish | Jul 1, 2016 | 10 years ago |
| SMA: Bullish | Jul 1, 2016 | 10 years ago |
| SMA: Bearish | Jan 1, 2016 | 10 years ago |
| SMA: Bearish | Jan 1, 2016 | 10 years ago |
| SMA: Bullish | Nov 1, 2015 | 11 years ago |
| SMA: Bullish | Nov 1, 2015 | 11 years ago |
| SMA: Bearish | Aug 1, 2015 | 11 years ago |
| MACD: Sell Signal | Jan 1, 2015 | 11 years ago |
| SMA: Bearish | Dec 1, 2014 | 11 years ago |
| RSI: Overbought | Apr 1, 2014 | 12 years ago |
| RSI: Overbought | Jan 1, 2014 | 12 years ago |
| SMA: Bullish | Jul 1, 2013 | 13 years ago |
| SMA: Bullish | Jul 1, 2013 | 13 years ago |
| SMA: Bearish | Jun 1, 2013 | 13 years ago |
| SMA: Bearish | Jun 1, 2013 | 13 years ago |
| SMA: Bullish | Mar 1, 2013 | 13 years ago |
| SMA: Bullish | Mar 1, 2013 | 13 years ago |
| SMA: Bearish | Feb 1, 2013 | 13 years ago |
| SMA: Bearish | Feb 1, 2013 | 13 years ago |
| SMA: Bullish | Jan 1, 2013 | 13 years ago |
| SMA: Bearish | Dec 1, 2012 | 13 years ago |
| SMA: Bullish | Nov 1, 2012 | 14 years ago |
| SMA: Bearish | Oct 1, 2012 | 14 years ago |
| SMA: Bullish | Sep 1, 2012 | 14 years ago |
| MACD: Buy Signal | Sep 1, 2012 | 14 years ago |
| SMA: Bullish | Jul 1, 2012 | 14 years ago |
| SMA: Bearish | Feb 1, 2012 | 14 years ago |
| SMA: Bearish | Feb 1, 2012 | 14 years ago |
| SMA: Bullish | Jan 1, 2012 | 14 years ago |
| SMA: Bullish | Jan 1, 2012 | 14 years ago |
| SMA: Bearish | Nov 1, 2011 | 15 years ago |
| SMA: Bullish | Oct 1, 2011 | 15 years ago |
| SMA: Bearish | Sep 1, 2011 | 15 years ago |
| MACD: Sell Signal | Aug 1, 2011 | 15 years ago |
| SMA: Bearish | Jul 1, 2011 | 15 years ago |
| SMA: Bullish | Apr 1, 2011 | 15 years ago |
| SMA: Bearish | Mar 1, 2011 | 15 years ago |
| SMA: Bullish | Jan 1, 2011 | 15 years ago |
| SMA: Bearish | Nov 1, 2010 | 16 years ago |
| SMA: Bullish | Jun 1, 2010 | 16 years ago |
| SMA: Bullish | Jun 1, 2010 | 16 years ago |
| SMA: Bearish | May 1, 2010 | 16 years ago |
| SMA: Bearish | Feb 1, 2010 | 16 years ago |
| SMA: Bullish | Jul 1, 2009 | 17 years ago |
| MACD: Buy Signal | Jun 1, 2009 | 17 years ago |
| SMA: Bullish | May 1, 2009 | 17 years ago |
| SMA: Bearish | Oct 1, 2008 | 18 years ago |
| SMA: Bullish | Jul 1, 2008 | 18 years ago |
| RSI: Oversold | Feb 1, 2008 | 18 years ago |
| SMA: Bearish | Aug 1, 2007 | 19 years ago |
| MACD: Sell Signal | Feb 1, 2007 | 19 years ago |
| SMA: Bearish | Dec 1, 2006 | 19 years ago |
| RSI: Overbought | Jul 1, 2006 | 20 years ago |
| SMA: Bullish | Jul 1, 2005 | 21 years ago |
| MACD: Buy Signal | Jul 1, 2005 | 21 years ago |
| SMA: Bearish | Jun 1, 2005 | 21 years ago |
| SMA: Bullish | Apr 1, 2005 | 21 years ago |
| SMA: Bullish | Apr 1, 2005 | 21 years ago |
| SMA: Bearish | Sep 1, 2004 | 22 years ago |
| MACD: Sell Signal | Sep 1, 2004 | 22 years ago |
| SMA: Bearish | Jun 1, 2004 | 22 years ago |
| SMA: Bullish | Sep 1, 2003 | 23 years ago |
| MACD: Buy Signal | May 1, 2003 | 23 years ago |
| SMA: Bullish | Apr 1, 2003 | 23 years ago |
| SMA: Bearish | May 1, 2002 | 24 years ago |
| SMA: Bearish | Apr 1, 2002 | 24 years ago |
| SMA: Bullish | Feb 1, 2002 | 24 years ago |
| SMA: Bearish | Sep 1, 2001 | 25 years ago |
| SMA: Bullish | Jul 1, 2001 | 25 years ago |
| SMA: Bearish | Apr 1, 2001 | 25 years ago |
| MACD: Sell Signal | Apr 1, 2001 | 25 years ago |
| SMA: Bullish | Mar 1, 2001 | 25 years ago |
| SMA: Bearish | Jan 1, 2001 | 25 years ago |
| MACD: Buy Signal | Aug 1, 2000 | 26 years ago |
| SMA: Bullish | Mar 1, 2000 | 26 years ago |
| SMA: Bullish | Mar 1, 2000 | 26 years ago |
| SMA: Bearish | Jan 1, 2000 | 26 years ago |
| SMA: Bearish | Jan 1, 2000 | 26 years ago |
| SMA: Bullish | Sep 1, 1999 | 27 years ago |
| SMA: Bullish | Aug 1, 1999 | 27 years ago |
| SMA: Bearish | Jul 1, 1999 | 27 years ago |
| SMA: Bearish | Apr 1, 1999 | 27 years ago |
| MACD: Sell Signal | Feb 1, 1999 | 27 years ago |
| MACD: Buy Signal | Jan 1, 1999 | 27 years ago |
| RSI: Overbought | Jan 1, 1999 | 27 years ago |
| SMA: Bullish | Nov 1, 1998 | 28 years ago |
| MACD: Sell Signal | Aug 1, 1998 | 28 years ago |
| SMA: Bearish | Jul 1, 1998 | 28 years ago |
| MACD: Buy Signal | Dec 1, 1997 | 28 years ago |
| MACD: Sell Signal | Nov 1, 1997 | 29 years ago |
| RSI: Overbought | Mar 1, 1995 | 31 years ago |
| RSI: Overbought | Dec 1, 1994 | 31 years ago |
| SMA: Bullish | Jul 1, 1994 | 32 years ago |
Key statistics
- Market cap
- 288.78B
- Enterprise value
- 297.95B
- Trailing P/E
- 27.83
- Forward P/E
- 16.41
- PEG ratio
- 1.23
- Price / sales
- 4.71
- Price / book
- 5.74
- EPS (TTM)
- 6.69
- Beta
- 0.21
- Dividend yield
- 1.84%
- Payout ratio
- 46.95%
- Profit margin
- 17.02%
- Revenue (TTM)
- 61.37B
- Revenue growth
- 6.40%
- Free cash flow
- 5.12B
- Total cash
- 4.97B
- Total debt
- 32.35B
- Return on equity
- 21.96%
- Shares outstanding
- 1.55B
- Short % of float
- 0.21%
- 50-day average
- 164.04
- 200-day average
- 180.19
Analyst view
Consensus: buy
- Target (low)
- 158.00
- Target (mean)
- 206.66
- Target (high)
- 240.00
- Strong buy2
- Buy7
- Hold2
- Sell1
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 2.41 | — | — | — |
| Oct 30, 2026 | Sep 30, 2026 | 2.60 | 2.79 | +0.19 | +7.31% |
| Jul 27, 2026 | Jun 30, 2026 | 2.50 | 2.63 | +0.13 | +5.20% |
| Apr 29, 2026 | Mar 31, 2026 | 2.57 | 2.58 | +0.01 | +0.39% |
| Feb 10, 2026 | Dec 31, 2025 | 2.09 | 2.12 | +0.03 | +1.44% |
| Nov 6, 2025 | Sep 30, 2025 | 2.28 | 2.38 | +0.10 | +4.39% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | CICC | init | — | Outperform |
| Feb 13, 2025 | UBS | up | Neutral | Buy |
| Nov 20, 2024 | UBS | up | Sell | Neutral |
| Sep 11, 2024 | Erste Group | up | Hold | Buy |
| Aug 12, 2024 | TD Cowen | main | Buy | Buy |
| May 30, 2024 | Argus Research | main | Buy | Buy |
About AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies for rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, USA, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of oral candidates; Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates; and Carterra, Inc. to advances lab-in-the-loop drug discovery through new scientific research collaboration. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is based in Cambridge, the United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- Website
- astrazeneca.com
News
- AstraZeneca (NYSE:AZN) Share Price Crosses Above 200 Day Moving Average – Time to Sell?
- AstraZeneca Plc $AZN Shares Acquired by Brian Low Financial Group LLC
- AstraZeneca (LON:AZN) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
- AstraZeneca PLC (AZN) Q3 2026 Earnings Call Transcript
- AstraZeneca Q3 Earnings Call Highlights
- AstraZeneca Q3 2026 Earnings Call Transcript
- AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales Growth
- AstraZeneca Stock Rallies on Q3 Earnings Beat, Double-Digit Oncology Growth
- AstraZeneca Stock Rallies on Q3 Earnings Beat, Double-Digit Oncology Growth
- Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Your note
Sign in to keep a note on AZN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BlackRock Financial Management, Inc. | — | Annual Return | Jan 30, 2026 | 100,885,181 |
| Broadley (Philip) | — | Annual Return | Dec 30, 2025 | 8,025 |
| Demare (Michel) | — | Bought | Sep 13, 2026 | 12,500 |
| Investor AB | — | Annual Return | Jan 30, 2026 | 51,587,810 |
| McCoy (Sherilyn S) | — | Annual Return | Dec 30, 2025 | 1,736 |
| Mok (Tony Shu Kam) | — | Annual Return | Dec 30, 2025 | 3,500 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Investor AB | 3.33% | 51,587,810 | 9.61B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.93% | 45,386,190 | 8.45B | Jun 29, 2026 |
| Capital International Investors | 2.23% | 34,576,070 | 6.44B | Jun 29, 2026 |
| NORGES BANK | 2.18% | 33,864,172 | 6.31B | Jun 29, 2026 |
| Capital World Investors | 1.94% | 30,075,134 | 5.60B | Jun 29, 2026 |
| FMR, LLC | 1.86% | 28,895,264 | 5.38B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 1.42% | 22,045,658 | 4.10B | Jul 30, 2026 |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 0.95% | 14,666,227 | 2.73B | Jun 29, 2026 |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 0.77% | 11,923,074 | 2.22B | Jun 29, 2026 |
| iShares Trust-iShares Core MSCI EAFE ETF | 0.74% | 11,467,645 | 2.14B | Sep 29, 2026 |
| NEW PERSPECTIVE FUND | 0.73% | 11,260,404 | 2.10B | Sep 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 0.66% | 10,300,505 | 1.92B | Jul 30, 2026 |